$42.50
0.250.59%
Pre-Market: Sep 20, 7:48 PM EDT
15 minutes delayed
Corcept Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-29 | $0.32 | $0.23 | 39.1 % |
Mar 2024 | 2024-05-01 | $0.25 | $0.22 | 13.6 % |
Dec 2023 | 2024-02-15 | $0.28 | $0.26 | 7.69 % |
Sep 2023 | 2023-11-01 | $0.28 | $0.21 | 33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-29 | $163.77M | $155.23M | 5.50 % |
Mar 2024 | 2024-05-01 | $146.81M | $140.80M | 4.27 % |
Dec 2023 | 2024-02-15 | $135.41M | $129.30M | 4.72 % |
Sep 2023 | 2023-11-01 | $123.60M | $119.34M | 3.57 % |
Corcept Therapeutics (CORT) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on July 29, 2024 for Q2.
The Actual EPS was $0.32, which beat the estimate of $0.23.
The Actual Revenue was $163.8M, which beat the estimate of $155.2M.
Browse earnings estimates, EPS, and revenue on all stocks.